Funding Clinical Trials

Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell-based treatments for challenging disease indications to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

ClinicalDashboardGraphic_102717.png

CIRM Clinical Dashboard

Disease Areas Investigatorsort descending Organization Phase Trial Status Targeted Enrollment Detail
Mehrdad Abedi University of California, Davis Phase 1/2 Suspended 18
Deborah Ascheim Capricor, Inc Phase 2 Active, not recruiting 24
Damien Bates SanBio, Inc. Phase 2 Active, not recruiting 156
Christine Brown City of Hope Phase 1 Recruiting 135
Mark Chao Forty Seven Inc. Phase 1 Not yet recruiting 96
Mark Chao Forty Seven Inc. Phase 1/2 Recruiting 112
Colleen Delaney Nohla Therapeutics Inc Phase 2 Not yet recruiting 220
Robert Dillman Caladrius Biosciences, Inc. Phase 3 Terminated 250
Paul Finnegan Angiocrine Bioscience, Inc. Phase 1 Launching N/A
Howard Foyt ViaCyte, Inc. Phase 1/2 Active, not recruiting 65
Howard Foyt ViaCyte, Inc. Phase 1/2 Recruiting 55
Anthony Gringeri ImmunoCellular Therapeutics Phase 3 Suspended 414
Mark Humayun University of Southern California Phase 1 Recruiting 20
Ralph Kern BrainStorm Cell Therapeutics Phase 3 Recruiting 200
Thomas Kipps University of California, San Diego Phase 1/2 Not yet recruiting 156
Thomas Kipps University of California, San Diego Phase 1/2 Recruiting 56
Henry Klassen University of California, Irvine Phase 1/2 Completed 28
Henry Klassen jCyte, Inc Phase 2 Recruiting 85
  • X-linked Chronic Granulomatous Disease
Donald Kohn University of California, Los Angeles Phase 1/2 Suspended 10
Donald Kohn University of California, Los Angeles Phase 1 Recruiting 6
Donald Kohn University of California, Los Angeles Phase 2 Recruiting 10
Nancy Lane University of California, Davis Phase 1/2 Recruiting 50
Jeffrey Lawson Humacyte, Inc. Phase 3 Recruiting 350
Jeffrey Lawson Humacyte, Inc. Phase 3 Not yet recruiting 240
Jane Lebkowski Geron Corporation Phase 1 Completed 5
Jane Lebkowski Asterias Biotherapeutics Phase 1/2 Active, not recruiting 35
  • Pulmonary Hypertension
Michael Lewis Cedars-Sinai Medical Center Phase 1/2 Recruiting 26
Douglas Losordo Caladrius Biosciences, Inc. Phase 2 Recruiting 111
  • Fetal Alpha Thalassemia Major
Tippi MacKenzie University of California, San Francisco Phase 1 Recruiting 10
Michael Pulsipher Children's Hospital of Los Angeles Phase 1/2 Launching N/A
Antoni Ribas University of California, Los Angeles Phase 1 Recruiting 12
Leonardo Sahelijo California Institute for Biomedical Research Phase 1 Not yet recruiting 60
Judith Shizuru Stanford University Phase 1/2 Recruiting 90
Dennis Slamon University of California, Los Angeles Phase 1 Recruiting 48
Rachel Smith Capricor, Inc Phase 2 Active, not recruiting 134
Brian Sorrentino St. Jude Children's Research Hospital Phase 1/2 Recruiting 28
  • Multiple Myeloma
Matthew Spear Poseida Therapeutics Phase 1 Recruiting 40
Samuel Strober Stanford University Phase 1 Recruiting 15
Clive Svendsen Cedars-Sinai Medical Center Phase 1/2 Recruiting 18
Geoff Symonds Calimmune, Inc. Phase 1/2 Active, not recruiting 12
Irving Weissman Stanford University Phase 1 Recruiting 96
Vicki Wheelock University of California, Davis Phase 1/2 Completed 29
John Zaia City of Hope Phase 1 Recruiting 12